Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 82

1.

A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use.

Beisland C, Guðbrandsdottir G, Reisæter LA, Bostad L, Hjelle KM.

World J Urol. 2016 Feb 27. [Epub ahead of print]

PMID:
26922650
3.

Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma.

Guðbrandsdottir G, Hjelle KM, Frugård J, Bostad L, Aarstad HJ, Beisland C.

Scand J Urol. 2015;49(5):388-94. doi: 10.3109/21681805.2015.1021833.

PMID:
25773545
4.

Contemporary external validation of the Leibovich model for prediction of progression after radical surgery for clear cell renal cell carcinoma.

Beisland C, Gudbrandsdottir G, Reisæter LA, Bostad L, Wentzel-Larsen T, Hjelle KM.

Scand J Urol. 2015 Jun;49(3):205-10. doi: 10.3109/21681805.2014.980844. Epub 2014 Nov 25.

PMID:
25423093
5.

Health-related quality of life in long-term survivors after renal cancer treatment.

Beisland C, Beisland E, Hjelle KM, Bostad L, Hjermstad MJ, Aarstad AK, Aarstad HJ.

Scand J Urol. 2014 Feb;48(1):52-64. doi: 10.3109/21681805.2013.813963. Epub 2013 Jul 24.

PMID:
23883326
6.

Incidentally detected renal cell carcinomas are highly associated with comorbidity and mortality unrelated to renal cell carcinoma.

Sand KE, Hjelle KM, Rogde ÅJ, Gudbrandsđottir G, Bostad L, Beisland C.

Scand J Urol. 2013 Dec;47(6):462-71. doi: 10.3109/21681805.2013.777364. Epub 2013 Mar 21.

PMID:
23517346
7.

Diagnostic yield of biopsies of cervical lymph nodes using a large (14-gauge) core biopsy needle.

Pedersen OM, Aarstad HJ, Løkeland T, Bostad L.

APMIS. 2013 Dec;121(12):1119-30. doi: 10.1111/apm.12058. Epub 2013 Mar 13.

PMID:
23489251
8.

Agalsidase benefits renal histology in young patients with Fabry disease.

Tøndel C, Bostad L, Larsen KK, Hirth A, Vikse BE, Houge G, Svarstad E.

J Am Soc Nephrol. 2013 Jan;24(1):137-48. doi: 10.1681/ASN.2012030316.

9.

Expression of apoptosis associated proteins Survivin, Livin and Thrombospondin-1 in Burkitt lymphoma.

Kalungi S, Wabinga H, Bostad L.

APMIS. 2013 Mar;121(3):239-45. doi: 10.1111/j.1600-0463.2012.02962.x. Epub 2012 Aug 8.

PMID:
23030305
10.

[A man in his fifties with fever, cough and anuria].

Rui PO, Svarstad E, Bostad L, Vikse BE.

Tidsskr Nor Laegeforen. 2012 Aug 7;132(14):1621-4. doi: 10.4045/tidsskr.11.0356. Norwegian. No abstract available.

11.

Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988-2010.

Tøndel C, Vikse BE, Bostad L, Svarstad E.

Clin J Am Soc Nephrol. 2012 Oct;7(10):1591-7. doi: 10.2215/CJN.02150212. Epub 2012 Jul 26.

12.

Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma.

Rogde AJ, Gudbrandsdottir G, Hjelle KM, Sand KE, Bostad L, Beisland C.

Scand J Urol Nephrol. 2012 Oct;46(5):348-57. doi: 10.3109/00365599.2012.678382. Epub 2012 Apr 25.

PMID:
22530756
13.

Long-term risk of ESRD in IgAN; validation of Japanese prognostic model in a Norwegian cohort.

Bjørneklett R, Vikse BE, Bostad L, Leivestad T, Iversen BM.

Nephrol Dial Transplant. 2012 Apr;27(4):1485-91. doi: 10.1093/ndt/gfr446. Epub 2011 Aug 5.

14.

Pre-transplant course and risk of kidney transplant failure in IgA nephropathy patients.

Bjørneklett R, Vikse BE, Smerud HK, Bostad L, Leivestad T, Hartmann A, Iversen BM.

Clin Transplant. 2011 May-Jun;25(3):E356-65. doi: 10.1111/j.1399-0012.2011.01424.x. Epub 2011 Mar 9.

PMID:
21651619
15.

Fabry or not Fabry--a question of ascertainment.

Houge G, Tøndel C, Kaarbøe O, Hirth A, Bostad L, Svarstad E.

Eur J Hum Genet. 2011 Nov;19(11):1111. doi: 10.1038/ejhg.2011.87. Epub 2011 May 18. No abstract available.

16.

Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease.

Najafian B, Svarstad E, Bostad L, Gubler MC, Tøndel C, Whitley C, Mauer M.

Kidney Int. 2011 Mar;79(6):663-70. doi: 10.1038/ki.2010.484. Epub 2010 Dec 15.

17.
18.

The RB (pRb2/p16) and p53 (p14/p53/p21) tumor-suppressor pathways in endemic Burkitt lymphoma.

Kalungi S, Wabinga H, Bostad L.

J Pediatr Hematol Oncol. 2011 Mar;33(2):e54-9. doi: 10.1097/MPH.0b013e3181edf543.

PMID:
21127431
19.

Thrombotic microangiopathy and the antiphospholipid syndrome.

Johnsen SJ, Valborgland T, Gudlaugsson E, Bostad L, Omdal R.

Lupus. 2010 Nov;19(13):1569-72. doi: 10.1177/0961203310375262. Epub 2010 Jul 20.

PMID:
20647251
20.

Previous preeclampsia and risk for progression of biopsy-verified kidney disease to end-stage renal disease.

Vikse BE, Hallan S, Bostad L, Leivestad T, Iversen BM.

Nephrol Dial Transplant. 2010 Oct;25(10):3289-96. doi: 10.1093/ndt/gfq169. Epub 2010 Mar 26.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk